Lymphomas involving Waldeyer's ring: Placement, paradigms, peculiarities, pitfalls, patterns and postulates

Annals of the Academy of Medicine Singapore

Volumn 33, Issue 4 SUPPL., 2004, Pages

  Tan, Leonard H C ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Differential diagnosis; Immunoarchitecture; Immunophenotyping; Mucosa associated lymphoid tissue; Regional variation

Indexed keywords

CD15 ANTIGEN; CD23 ANTIGEN; CD31 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD99 ANTIGEN; CYCLIN D1; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE ANTIGEN; MYC PROTEIN; NERVE CELL ADHESION MOLECULE; PROTEIN BCL 2; SYNDECAN 1; T LYMPHOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER STATISTICS; CHILD; CONFERENCE PAPER; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; FOLLICULAR LYMPHOMA; GENERAL HOSPITAL; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPH NODE HYPERPLASIA; LYMPHOEPITHELIOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NASOPHARYNX CARCINOMA; NATURAL KILLER CELL; PLASMACYTOMA; SINGAPORE; T CELL LYMPHOMA; WALDEYER RING;

EID: 8144220025     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (60)

1. nd ed. Philadelphia: Lippincott-Raven, 1997:391-404.
2. Isaacson PG, Norton AJ. Extranodal lymphomas. Edinburgh: Churchill Livingstone, 1994:195-215.
3. Normal anatomy and function of lymph nodes and spleen. In: Wamke RA, Weiss LM, Chan JKC, Cleary ML, Dorfman RF, editors. Tumors of the Lymph Nodes and Spleen. Atlas of Tumor Pathology. Fascicle 14. 3rd Series. Washington DC: US Armed Forces Institute of Pathology, 1994:3-14.
4. nd ed. Edinburgh: Churchill Livingstone, 1992:3-28.
5. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues. Lyon: WHO classification of tumours, International Agency for Research on Cancer, 2001.
6. Paulsen J, Lennert K. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type in Waldeyer's ring. Histopathology 1994;24:1-11.
7. Menarguez J, Mollejo M, Carrion R, Oliva H, Bellas C, Forteza J, et al. Waldeyer ring lymphomas. A clinicopathological study of 79 cases. Histopathology 1994;24:13-22.
8. Swerdlow SH, Williams ME. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol 2002;33:7-20.
9. Krol AD, Le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Waldeyer's ring lymphomas: a clinical study from the Comprehensive Cancer Center West population based NHL Registry. Leuk Lymphoma 2001;42:1005-13.
10. Yoshino T, Miyake K, Ichimura K, Mannami T, Ohara N, Hamzaki B, et al. Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol 2000;24:688-93.
11. Shia J, Teruya-Feldstein J, Pan D, Hegde A, Klimstra DS, Chaganti RS, et al. Primary follicular lymphoma of the gastrointestinal tract. A clinical and pathologic study of 26 cases. Am J Surg Pathol 2002;26:216-24.
12. 7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol 2003;162:105-13.
13. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-10.
14. Ye YL, Zhou MH, Lu XY, Dai YR, Wu WX. Nasopharyngeal and nasal malignant lymphoma: a clinicopathological study of 54 cases. Histopathology 1992;20:511-6.
15. Ambinder RF. Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 2001;37:1209-16.
16. Knecht H, Berger C, Rothenberger S, Odermatt BF, Brousset P. The role of Epstein-Barr virus in neoplastic transformation. Oncology 2001;60:289-302.
17. Kurth J, Spieker T, Wustrow J, Strickler JG, Hansmann ML, Rajewsky K, et al. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 2000;13:485-95.
18. Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 1995;85:744-50.
19. Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crocker J, et al. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 1992;79:2520-6.
20. Cabone A, Gaidano G, Gloghini A, Larocca LM, Capello D, Canzonieri V, et al. Differential expression of BCL-6 and CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 1998;91:747-55.
21. Cabone A, Gaidano G, Gloghini A, Pastore C, Saglio G, Tirelli U, et al. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. Am J Pathol 1997;150:155-65.
22. Cabone A, Gloghini A, Gaidano G, Francheschi S, Capello D, Drexler HG, et al. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. Blood 1998;92:2220-8.
23. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, et al. BCL-6 protein is expressed in germinal-center B cells. Blood 1995;86:45-53.
24. Jochner N, Eick D, Zimber-Strobl U, Pawlita M, Bornkamm GW, Kempkes B. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin μ gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. EMBO J 1996; 15:375-82.
25. Uherova P, Ross CW, Finn WG, Singleton TP, Kansal R, Schnitzer B. Peripheral T-cell lymphoma mimicking marginal zone B-cell lymphoma. Mod Pathol 2002; 15:420-5.
26. Govender D, Harilal P, Dada M, Chetty R. CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells. J Clin Pathol 1997;50:490-3.
27. Ely SA, Knowles DM. Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation. Am J Pathol 2002;160:1293-9.
28. Pellat-Deceunynck C, Barille S, Puthier D, Rapp MJ, Harousseau JL, Bataille R, et al. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. Cancer Res 1995;55:3647-53.
29. Sahara N, Takeshita A, Shigeno K, Fujisawa S, Takeshita K, Naito K, et al. Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma. Br J Haematol 2002;117:882-5.
30. Isaacson PG. Lymphoproliferative disorders. In: Anthony PP, editor. Diagnostic Pitfalls in Histopathology and Cytopathology Practice. London: Greenwich Medical Media, 1998:73-87.
31. nd ed. Edinburgh: Churchill Livingstone, 1992:55-116.
32. Salvador AH, Harrison EG, Kyle RA. Lymphadenopathy due to infectious mononucleosis: its confusion with malignant lymphoma. Cancer 1971;27:1029-40.
33. Tindle BH, Parker JW, Lukes RJ. "Reed-Sternberg cells" in infectious mononucleosis? Am J Clin Pathol 1972;58:607-17.
34. Childs CC, Parham DM, Berard CW. Infectious mononucleosis. The spectrum of morphologic changes simulating lymphoma in lymph nodes and tonsils. Am J Surg Pathol 1987;11:122-32.
35. Strickler JG, Fedeli F, Horwitz CA, Copenhaver CM, Frizzera G. Infectious mononucleosis in lymphoid tissue. Histopathology, in situ hybridization and differential diagnosis. Arch Pathol Lab Med 1993;117:269-78.
36. Isaacson PG, Schmid C, Pan LX, Wotherspoon AC, Wright DH. Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis. J Pathol 1992; 167:267-271.
37. Reynolds DJ, Banks PM, Gulley ML. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease. Am J Pathol 1995;146:379-88.
38. Kim SH, Choi EY, Shin YK, Kim TJ, Chung DH, Chang SI, et al. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (Mic2). Blood 1998;92:4287-95.
39. Kim SH, Shin YK, Lee IS, Bae YM, Sohn HW, Suh Y H, et al. Viral latent membrane protein 1 (LMP-1)-induced CD99 down-regulation in B cells leads to the generation of cells with Hodgkin's and Reed-Sternberg phenotype. Blood 2000:95:294-300.
40. Park CK, Shin YK, Kim TJ, Park SH, Ahn GH. High CD99 expression in memory T and B cells in reactive lymph nodes. J Korean Med Sci 1999;14:600-6.
41. Hahn JH, Kim MK, Choi EY, Kim SH, Sohn HW, Ham DI, et al. CD99 (MIC2) regulates the LFA/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J Immunol 1997;159:2250-8.
42. Waclavicek M, Majdic O, Stulnig T, Berger M, Sunder-Plassmann R, Zlabinger GJ, et al. CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J Immunol 1998;161:4671-8.
43. Wingett D, Forcier K, Neilson CP. A role for CD99 in T cell activation. Cell Immunol 1999;193:17-23.
44. Schwarting R, Gerdes J, Durkop H, Falini B, Pileri S, Stein H. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989;74:1678-89.
45. Chiarle R, Podda A, Prolla G, Gong J, Thorbecke GJ, Inghirami G. CD30 in normal and neoplastic cells. Clin Immunol 1999;90:157-64.
46. Rushin JM, Riordan GP, Heaton RB, Sharpe RW, Cotelingam JD, Jaffe ES. Cytomegalovirus-infected cells express Leu-M1 antigen. A potential source of diagnostic error. Am J Pathol 1990;136:989-95.
47. Brown RW, Clark GM, Tandon AK, Allred DC. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 1993;24:347-54.
48. Kapadia SB, Roman LN, Kingma DW, Jaffe ES, Frizzera G. Hodgkin's disease of Waldeyer's ring. Clinical and histoimmunophenotypic findings and association with Epstein-Barr virus in 16 cases. Am J Surg Pathol 1995;19:1431-9.
49. Hertel CB, Zhou XG, Hamilton-Dutoit SJ, Junker S. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells ofclassical Hodgkin lymphoma. Oncogene 2000;21:4908-20.
50. Marafioti T, Hummel M, Foss HD, Lauman H, Korbjuhn P, Anagnostopoulos 1, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000;95:1443-50.
51. Calame C, Lin KI, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 2003;21:205-30.
52. Shanmugaratnam K, Chan SH, de-The G, Goh JE, Khor TH, Simons MJ, et al. Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics. Cancer 1979;44:1029-44.
53. Shanmugaratnam K. Histopathological aspects of nasopharyngeal carcinoma. In: Wagner G, Zhang YH, editors. Cancer of the Liver, Oesophagus and Nasopharynx. Heidelberg: Springer-Verlag, 1985:152-9.
54. Dubey P, Ha CS, Ang KK, El-Naggar AK, Knapp C, Byers RM, et al. Non-nasopharyngeal lymphoepithelioma of the head and neck. Cancer 1998;82:1556-62.
55. Mills SE, Gaffey MJ, Frierson HF. Tumors of the upper aerodigestive tract and ear. In: Rosai J, Sobin LH, editors. Atlas of Tumor Pathology. Fascicle 26. 3rd Series. Washington DC: US Armed Forces Institute of Pathology, 2000:88-96.
56. Beck A, Pazolt D, Grabenbauer GG, Nicholls JM, Herbst H, Young LS, et al. Expression ofcytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease. J Pathol 2001:194:145-51.
57. Chittal S, Al Saati T, Delsol G. Epithelial membrane antigen in hematolymphoid neoplasms. A review. Appl Immunohistochem 1997;5:203-15.
58. Chan JK. Advances in immunohistochemistry: impact on surgical pathology practice. Semin Diagn Pathol 2000;17:170-7.
59. Maggio E, van den Berg A, Diepstra A, Kluiver J, Visser L, Poppema S. Chemokines, cytokines and their receptors in Hodgkin's Lymphoma cell lines and tissues. Ann Oncol 2002:13(Suppl 1):52-6.
60. Seitz V, Hummel M, Walter J, Stein H. Evolution of classic Hodgkin lymphoma in correlation to changes in the lymphoid organ structure of vertebrates. Dev Comparative Immunol 2003;27:43-53.